JENA, Germany, February 7 /PRNewswire/ -- Occlutech GmbH, the leading European manufacturer of coronary occlusion devices today announced that it has obtained approval for its IP position in relation to patents held by AGA Medical Inc. from AIPPI, the European International Association for the Protection of Intellectual Property.

AIPPI is the world's leading non-government organization for research into and protection of intellectual property, and is a respected source for opinions and arbitration on IP matters such as patent interpretation and the use of IP in unfair competition.

Lice from 1,000-year-old mummies in Peru may unravel important clues about a different sort of passage: the migration patterns of America’s earliest humans, a new University of Florida study suggests.

“It’s kind of quirky that a parasite we love to hate can actually inform us how we traveled around the globe,” said David Reed, an assistant curator of mammals at the Florida Museum of Natural History on the UF campus and one of the study’s authors.

DNA sequencing found the strain of lice to be genetically the same as the form of body lice that spawns several deadly diseases, including typhus, which was blamed for the loss of Napoleon’s grand army and millions of other soldiers, he said.

Over 70 percent of high school teachers are female and girls in high school take as many math courses as boys, yet it's believed female interest in math and science still wanes considerably in high school and college.

A new study conducted by researchers at the University of Texas at Austin, the University of Pennsylvania, and Michigan State University published in Child Development says girls, more than boys, look to their close friends when they make important decisions such as whether to take math and what math classes to take, confirming how significant peers are during adolescence.

There are two mistakes you can make when you read a scientific paper: You can believe it (a) too much or (b) too little. The possibility of believing something too little does not occur to most professional scientists, at least if you judge them by their public statements, which are full of cautions against too much belief and literally never against too little belief. Never. If I’m wrong — if you have ever seen a scientist warn against too little belief — please let me know. Yet too little belief is just as costly as too much.

At today’s IEEE International Solid State Circuit Conference, IMEC introduced its prototype of a 60GHz multiple antenna receiver, and invites industry to join its 60GHz research program. The 60GHz band offers massive available bandwidth that enables very high bit rates of several Gbits-per-second at distances up to 10 meters (about 33 feet).

To make the 60GHz technology cost-efficient to manufacture, low power and affordable in consumer products, IMEC has built its RF solution in a standard digital CMOS process thereby avoiding the extra cost of alternative technologies or dedicated RF process options.

The second industry goal is to overcome high path losses at mm-wave frequencies by using a phased antenna array approach.

NEW YORK, February 7 /PRNewswire/ --

Hudson Highland Group, Inc. (Nasdaq: HHGP), one of the world's leading providers of permanent recruitment, contract professionals and talent management solutions, today announced financial results for the fourth quarter and full-year ended December 31, 2007.

MONTREAL, Canada, February 6 /PRNewswire/ --

- Shipment of Prion Capture Resin to MacoPharma in Q1 2008;

- MacoPharma Increased its Forecast for P-Capt(R) Filters Sale in 2008;

- Use of Affinity Prion Adsorbent for Plasma-Derived Products to Generate in Excess of CAD$25 M Over the Next 5 Years - CAD$4 M in 2008;

- 10th Product Approved by the FDA and or the EMEA, Contributing to Revenue Growth.

ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") today provided an update on its business activities.

Thousands of times a year, a single cell extraction from an embryo is performed to screen for genetic diseases. As of January 2008, the cell could be allowed to divide and the copy used for research without harm to the embryo. Current federal funding is prohibited for experiments that injure or destroy human embryonic stem cells and is limited to cells extracted before President Bush's declaration of August 9, 2001. Meanwhile, four hundred thousand embryos are sitting in clinics waiting to be implanted in the mother's womb or to be discarded – a practice of which no one has raised a disapproving eyebrow. However, rapid advances in stem cell extraction methodology are quickly laying ethical issues to rest. As of January, 2008, stem cell research has laid a golden egg. Thousands of times a year a single cell is taken from an embryo to screen for genetic diseases. Advanced Cell Technology now has the capability to allow the cell to divide in a laboratory dish and use the copy for stem cells.

A new study documents malformations seen in an infant born to a kidney transplant recipient who had taken mycophenolate mofetil (MMF), a widely used immunosuppressant available commercially as Cellcept®. The findings suggest a specific birth defect pattern particular to this drug, reinforcing its potential to harm to the fetus.

Approximately 14,000 births to organ transplant recipients, primarily kidney transplant patients, have been reported worldwide. Although pregnancy was initially ill-advised for these women, the American Society of Transplantation concluded in 2003 that pregnancy is usually safe following the first year of a transplant, provided that organ rejection or other complications have not occurred. The fetal side-effects of several immunosuppressant drugs have been studied, though not for widely used newer medications, such as (MMF).

CHICAGO and PARIS, February 6 /PRNewswire/ --

- Leading North American Traffic Provider to Launch Multiple European Products in 2008

NAVTEQ (NYSE: NVT), a leading global provider of digital map data for vehicle navigation and location based solutions, today announced the expansion of NAVTEQ Traffic to Europe. The company has announced plans to introduce both its real-time NAVTEQ Traffic product and NAVTEQ Traffic Patterns, a product featuring historic traffic data that further optimizes routing in navigation systems and on-line mapping, in Europe in 2008.